167 related articles for article (PubMed ID: 33467082)
21. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F
Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
[TBL] [Abstract][Full Text] [Related]
22. Human breast carcinoma cells are induced to apoptosis by samsum ant venom through an IGF-1-dependant pathway, PI3K/AKT and ERK signaling.
Badr G; Garraud O; Daghestani M; Al-Khalifa MS; Richard Y
Cell Immunol; 2012; 273(1):10-6. PubMed ID: 22218396
[TBL] [Abstract][Full Text] [Related]
23. Deltonin induces apoptosis in MDA‑MB‑231 human breast cancer cells via reactive oxygen species‑mediated mitochondrial dysfunction and ERK/AKT signaling pathways.
Zhang S; He Y; Tong Q; Chen Q; Wu X; Huang W
Mol Med Rep; 2013 Mar; 7(3):1038-44. PubMed ID: 23314115
[TBL] [Abstract][Full Text] [Related]
24. Simvastatin-induced breast cancer cell death and deactivation of PI3K/Akt and MAPK/ERK signalling are reversed by metabolic products of the mevalonate pathway.
Wang T; Seah S; Loh X; Chan CW; Hartman M; Goh BC; Lee SC
Oncotarget; 2016 Jan; 7(3):2532-44. PubMed ID: 26565813
[TBL] [Abstract][Full Text] [Related]
25. Selenocystine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation.
Chen T; Wong YS
J Agric Food Chem; 2008 Nov; 56(22):10574-81. PubMed ID: 18959417
[TBL] [Abstract][Full Text] [Related]
26. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor.
Hollier BG; Kricker JA; Van Lonkhuyzen DR; Leavesley DI; Upton Z
Endocrinology; 2008 Mar; 149(3):1075-90. PubMed ID: 18079201
[TBL] [Abstract][Full Text] [Related]
27. CLA reduces breast cancer cell growth and invasion through ERalpha and PI3K/Akt pathways.
Bocca C; Bozzo F; Cannito S; Colombatto S; Miglietta A
Chem Biol Interact; 2010 Jan; 183(1):187-93. PubMed ID: 19800873
[TBL] [Abstract][Full Text] [Related]
28. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H
J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917
[TBL] [Abstract][Full Text] [Related]
29. [Cytoskeleton structures and adhesion properties of human stromal precursors under conditions of simulated microgravity].
Gershovich PM; Gershovich IuG; Buravkova LB
Tsitologiia; 2009; 51(11):896-904. PubMed ID: 20058807
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway.
Luey BC; May FE
Mol Cancer; 2016 Jan; 15():8. PubMed ID: 26801096
[TBL] [Abstract][Full Text] [Related]
31. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
Han YC; Zeng XX; Wang R; Zhao Y; Li BL; Song M
Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
[TBL] [Abstract][Full Text] [Related]
32. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
Xu J; Zuo D; Qi H; Shen Q; Bai Z; Han M; Li Z; Zhang W; Wu Y
Biomed Pharmacother; 2016 Mar; 78():308-321. PubMed ID: 26898456
[TBL] [Abstract][Full Text] [Related]
33. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
34. Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of clonogenic resistance in breast cancer cells by combined cisplatin and FK228.
Pluchino LA; Choudhary S; Wang HC
Cancer Lett; 2016 Oct; 381(1):124-32. PubMed ID: 27477899
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia confers protection against apoptosis via PI3K/Akt and ERK pathways in lung cancer cells.
Lee SM; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
Cancer Lett; 2006 Oct; 242(2):231-8. PubMed ID: 16427189
[TBL] [Abstract][Full Text] [Related]
36. Chrysophanol selectively represses breast cancer cell growth by inducing reactive oxygen species production and endoplasmic reticulum stress via AKT and mitogen-activated protein kinase signal pathways.
Park S; Lim W; Song G
Toxicol Appl Pharmacol; 2018 Dec; 360():201-211. PubMed ID: 30300626
[TBL] [Abstract][Full Text] [Related]
37. Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.
de Sousa Mesquita AP; de Araújo Lopes S; Pernambuco Filho PCA; Nader HB; Lopes CC
Apoptosis; 2017 Sep; 22(9):1116-1137. PubMed ID: 28653224
[TBL] [Abstract][Full Text] [Related]
38. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells.
Ma Y; Yu WD; Kong RX; Trump DL; Johnson CS
Cancer Res; 2006 Aug; 66(16):8131-8. PubMed ID: 16912191
[TBL] [Abstract][Full Text] [Related]
39. ERK1/2 and Akt pathway activated during (3R,6R)-bassiatin(1)-induced apoptosis in MCF-7 cells.
Meng L; Tao H; Dong G; Yang T; Zhang W; Zhu W; Huang C
Cell Biol Int; 2012 Apr; 36(4):345-8. PubMed ID: 22150072
[TBL] [Abstract][Full Text] [Related]
40. Extracellular matrix secreted by senescent fibroblasts induced by UVB promotes cell proliferation in HaCaT cells through PI3K/AKT and ERK signaling pathways.
Kang J; Chen W; Xia J; Li Y; Yang B; Chen B; Sun W; Song X; Xiang W; Wang X; Wang F; Bi Z; Wan Y
Int J Mol Med; 2008 Jun; 21(6):777-84. PubMed ID: 18506372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
